Literature DB >> 11976803

(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection.

Achim H Kaim1, Bruno Weber, Michael O Kurrer, Gerrit Westera, Alain Schweitzer, Jochen Gottschalk, Gustav K von Schulthess, Alfred Buck.   

Abstract

The aim of this study was to compare the uptake of (18)F-fluoroethyl- L-tyrosine ((18)F-FET) with that of (18)F-fluorodeoxyglucose ((18)F-FDG) in activated inflammatory white blood cells. Unilateral thigh muscle abscesses were induced in 11 rats by intramuscular inoculation of 0.1 ml of a bacterial suspension ( S. aureus, 1.2 x 10(9) CFU/ml). Four animals were intraperitoneally injected with 130-180 MBq (18)F-FDG, four with 140-170 MBq (18)F-FET and three with a mixture of 140-170 MBq (18)F-FET and 1.8 MBq (14)C-deoxyglucose. Autoradiography (10 microm slice thickness) of the abscess and the contralateral muscle was performed and detailed spatial correlation of autoradiography and histopathology (haematoxylin-eosin staining) was obtained. Regions of interest were placed on the abscess wall and the grey values (digitised image intensities) measured were converted to kBq/cc per kBq injected activity per gram (SUV). Areas with increased (18)F-FDG uptake corresponded to cellular inflammatory infiltrates mainly consisting of granulocytes. The SUV was calculated to be 4.08+/-0.65 (mean+/-SD). The uptake of (18)F-FET in activated white blood cells was not increased: the SUV of the abscess wall, at 0.74+/-0.14, was even below that of contralateral muscle. The low uptake of (18)F-FET in non-neoplastic inflammatory cells promises a higher specificity for the detection of tumour cells than is achieved with (18)F-FDG, since the immunological host response will not be labelled and inflammation can be excluded.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976803     DOI: 10.1007/s00259-002-0780-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  21 in total

1.  MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

Authors:  Nathalie L Jansen; Vera Graute; Lena Armbruster; Bogdana Suchorska; Juergen Lutz; Sabina Eigenbrod; Paul Cumming; Peter Bartenstein; Jörg-Christian Tonn; Friedrich Wilhelm Kreth; Christian la Fougère
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-11       Impact factor: 9.236

2.  Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies.

Authors:  Ehab M Kamel; Thomas A McKee; Maria-Lucia Calcagni; Sabine Schmidt; Serge Markl; Sandra Castaldo; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-22       Impact factor: 9.236

Review 3.  Radionuclide imaging of spinal infections.

Authors:  Filip Gemmel; Nicolas Dumarey; Christopher J Palestro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

4.  18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.

Authors:  Stephan Kurt Haerle; Dorothee R Fischer; Daniel T Schmid; Nader Ahmad; Gerhard F Huber; Alfred Buck
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

5.  Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.

Authors:  Dirk Pauleit; Frank Floeth; Hans Herzog; Kurt Hamacher; Lutz Tellmann; Hans-W Müller; Heinz H Coenen; Karl-J Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-02-15       Impact factor: 9.236

6.  Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.

Authors:  Barbara Stöber; Ursula Tanase; Michael Herz; Christof Seidl; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-08       Impact factor: 9.236

7.  Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.

Authors:  Gabriele Pöpperl; Claudia Götz; Walter Rachinger; Franz-Josef Gildehaus; Jörg-Christian Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-10       Impact factor: 9.236

8.  Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.

Authors:  Nicolas Spaeth; Matthias T Wyss; Jens Pahnke; Gregoire Biollaz; Amelie Lutz; Kerstin Goepfert; Gerrit Westera; Valerie Treyer; Bruno Weber; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

9.  Significance of FDG-PET in Identification of Diseases of the Appendix - Based on Experience of Two Cases Falsely Positive for FDG Accumulation.

Authors:  Shimpei Ogawa; Michio Itabashi; Shingo Kameoka
Journal:  Case Rep Gastroenterol       Date:  2009-04-29

10.  [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Authors:  Markus Hutterer; Martha Nowosielski; Daniel Putzer; Nathalie L Jansen; Marcel Seiz; Michael Schocke; Mark McCoy; Georg Göbel; Christian la Fougère; Irene J Virgolini; Eugen Trinka; Andreas H Jacobs; Günther Stockhammer
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.